Mobile genetic Elements (MEs) are segments of DNA which, through an RNA intermediate, 26 can generate new copies of themselves and other transcribed sequences through the 27 process of retrotransposition (RT). In humans several disorders have been attributed to RT, 28 but the role of RT in severe developmental disorders (DD) has not yet been explored. As 29 such, we have identified RT-derived events in 9,738 whole exome sequencing (WES) trios 30 with DD-affected probands as part of the Deciphering Developmental Disorders (DDD) 31 study. We have ascertained 9 de novo MEs, 4 of which are likely causative of the patient's 32 symptoms (0.04% of probands), as well as 2 de novo gene retroduplications. Beyond 33 identifying likely diagnostic RT events, we have estimated genome-wide germline ME 34 mutagenesis and constraint and demonstrated that coding RT events have signatures of 35 purifying selection equivalent to those of truncating mutations. Overall, our analysis 36 represents the single largest interrogation of the impact of RT activity on the coding genome 37 to date. 38
in the etiology of rare disease, and if routine clinical sequencing should assess patient 66 genomes for deleterious RT events. 67 We analyzed the WES data produced by the Deciphering Developmental Disorders 68 (DDD) study to systematically assess the role of RT in severe developmental disorders 69 (DDs). The DDD data have already been investigated for pathogenic single nucleotide 70 variants (SNVs), small insertions and deletions (InDels), large copy number variants (CNVs), 71 and other classes of structural variation [12] [13] [14] [15] [16] [17] [18] . Approximately 24% of DDD cases harbour a 72 pathogenic de novo mutation in a gene known to be associated with developmental 73 disorders 12 . The DDD cohort should thus be relatively enriched for highly penetrant de novo 74 RT events in comparison to recent studies on autism. With a cohort of 9,738 trios (n = 75 28,132 individuals) whole exome sequenced, the DDD study presents a powerful opportunity 76 to identify, and ascertain the role in DD of, pathogenic de novo RT events that impact coding 77 sequences. 78
Generation of a genome-wide dataset of RT variants 80 To assess 9,738 DDD study trios for RT events we utilized two separate 81 computational approaches to identify both MEIs and PPGs. First, we used the Mobile 82 Element Locator Tool (MELT) 5 to identify Alu, L1, and SVA variants located within the WES 83 bait regions (Methods). The second is a new bespoke tool developed to identify PPGs from 84 WES data (Methods, Supplemental Fig. 1 ). Due to cross-hybridisation between a PPG and 85 the exome baits targeting the donor gene, we anticipated that we should be able to detect 86 PPGs genome-wide, not just the subset that insert within the WES bait regions. Our PPG 87 detection tool ascertained putative PPGs by identifying multiple discordant read pairs 88 mapping to different exons of the same transcript, before then typing all individuals for the 89 presence/absence of the PPG using discordant read-pairs and split reads. The tool was 90 optimized by comparing against previously described PPG polymorphisms in the 1000 As our study is the first to discover MEIs directly from WES on a large scale, we first 97 utilized matched sample WGS data to determine if MELT could ascertain MEI variants 98 reliably from WES data. We compared MEI variants identified by MELT within the DDD WES 99 data to both WGS data generated on the same individuals and population MEI data 100 previously generated from the 1000 Genomes Project Phase 3 (1KPG) 4-6 WGS data. The 101 latter comparison was to ensure that the number of exonic MEIs identified within DDD WES 102 data was concordant with expectations at the individual and population level. When 103 comparing our WES genotypes to WGS in identical individuals, we had a genotype 104 concordance rate of 94.46% (93.93% Alu, 97.29% L1, 98.25% SVA) among calls with at 105 least 10X coverage in our WES data. In total, we were able to re-identify 1,355 (1,289 Alu, 106 160 L1, 1 SVA) MEI genotypes, or 84.5% of all heterozygous or homozygous genotypes 107 identifiable with WGS in WES bait regions (Supplemental Table 1 ). Based on these findings 108 we were confident that MELT was appropriately calibrated to ascertain MEIs in WES data. 109
We identified 1,129 MEI variants and 576 polymorphic PPGs, with each individual's 110 exome containing on average 33.5±7.3 variants. All MEIs were genotyped across all 111 individuals to form a comprehensive catalogue of RT-derived variation within and adjacent to 112 MEIs (16.0% of measured variants), while in previous studies ~30% of all L1 MEIs are full-125 length. As MELT was previously validated for MEI length measurement 5 , our conclusion is 126 that we have lower sensitivity for ascertainment of longer L1s from WES. 127 given gene) to a recent assessment of PPGs in samples sequenced as part of the 1KGP 6 . 144
Generally, PPGs identified in both data sets shared similar relative allele counts (r 2 = 0.64) 145
and variants identified in this study but missing from Zhang et. al. 6 are typically rare 146 (Supplemental Fig. 3 ). To further validate our approach and ensure that the identified PPG 147 donor genes fit with previously identified patterns of germline PPG formation 2,19 , we 148 assessed each donor gene for both functional annotation and expression across 30 tissue 149 types analyzed by the GTEx consortium 20 . The major functional cluster (DAVID 21 enrichment 150 score 8.82) belonged to genes involved in the ribosomal and translational machinery, 151 consistent with previous findings involving fixed PPGs in the human genome 2 . Our 152 expression analysis likewise confirmed previous findings 19 , and shows that donor genes that 153
give rise to PPGs are more highly expressed in a large number of tissues compared to non-154 retroposed genes (Wilcoxon rank sum p < 1x10 -3 for all tissues; Supplemental Fig. 4 ). 155
Additionally, while it could be assumed that increased germ-line expression of a gene may 156 play a role in increased probability of PPG generation, when we compared PPG donor gene 157 expression in the testis and ovary to that in other tissues, the majority of tissues (20/29, 158 identical tissues for ovary and testis) showed statistically identical patterns of donor gene 159 expression (Wilcoxon rank sum p > 1x10 -3 ; Supplemental Fig. 4 ). 160
161
Coding RT burden and constraint 162 As expected for WES, the vast majority (84.9%) of MEIs impacted the coding or 163 intronic sequence of a protein-coding gene or a regulatory element targeted in the 164 augmented WES assay described in Short et. al. 15 (Fig. 2a ). While the number of MEIs 165 identified in this study, based on the proportion of the genome assayed, represent only 2.2% 166 of genome-wide MEI variants, we have ascertained over five-fold more variants that directly 167 impact exons than the next largest study (Supplemental Fig. 5 ) 4,5 . 168
Our large collection of coding variants allowed us to examine the evolutionary forces common measures: the proportion of variants observed in only one individual (e.g. 171 singletons) 22 and the proportion of variants found in genes likely to be intolerant of loss of 172 function (LoF) as determined by the pLI score 23 . To avoid issues of relatedness and the 173 potential for clinical ascertainment bias for pathogenic MEIs in individual DD patients, only 174 the 17,032 unaffected parents sequenced as part of DDD were included in our analysis. 175
MEIs which directly impact exons are under strong selective constraint, indistinguishable 176 from that of both nonsense and essential splice site SNVs (Fig. 2b ). Interestingly, we did not 177 find any sign of selection acting on intronic MEIs as they appear to be constrained similarly 178 to synonymous SNVs. In contrast to previous studies 24,25 , we did not find a statistically 179 significant (c 2 p < 0.05) bias towards intronic MEIs inserted in the antisense orientation of 180 the gene in which they are found (Supplemental Fig. 6 ). This is likely not a repudiation of 181 such work, but attributable to the relatively small number of intronic events we identified as 182 part of our analysis compared to WGS 4,24 or reference genome-based 25 distinguishing between different PPGs for the same donor gene, we were able to assess the 201 propensity for specific genes to give rise to PPGs based on their selective constraint. We 202 observed that PPG donor genes were significantly enriched for genes that are highly 203 intolerant of loss of function variation (pLI > 0.9). High pLI genes make up 25.3% of donor 204 genes, compared to 17.6% of all protein-coding genes (c 2 p = 2.4x10 -6 ) 22 . This observation is 205 likely driven by loss of function intolerant genes being more likely to be highly expressed in 206 multiple tissues 22 , similar to genes known to have been retroduplicated (Supplemental Table 2) and,  217 where possible, inspected for poly(A) tail and target site duplication -hallmarks of bona fide 218 RT activity 28 . We identified no de novo RT variants which localized to the non-coding 219 elements included on the WES capture, which falls in line with expectations based on 220 mutation rate estimates ( Fig. 4b ). We also attempted to determine the parental origin of each 221 RT event using SNVs located on sequencing reads which support the RT insertion (Table 2) . 222
Of the 11 de novo RT events, we were able to phase three variants, all to the father. While 223 this finding is not statistically significant (c 2 p = 0.083), it fits with previous findings that the majority of de novo structural variants 9 , and indeed most variant classes 29 , are attributable to 225 paternal origin. 226
Nine of our validated de novo mutations were MEIs (7 Alu, 2 L1), or a rate of 227 approximately one de novo event per every 1,000 patient exomes sequenced (9/9,738). As 228 expected, based on both the total number of polymorphisms 3-5 and mutation rate (Table 1;  229   Supplemental Table 4 ), we identified more Alu de novo variants than the other RT classes. 230
We also identified 2 PPG germ-line de novo variants, or approximately one new PPG per 231 every 5,000 patient whole genomes sequenced (2/9,738). As a further quality control for 232
PPGs, we capillary sequenced all resulting PCR products to confirm the gene of origin 233 (Supplemental Data 1) and performed WGS to identify the PPG insertion site. We were able 234 to localize the SERINC5 PPG to an ~50Kbp intron of the gene CLIC4 and the SLC35F2 235 event to an intergenic region between the genes MAK and GCM2 (Fig. 3e ). Neither of the 236 events directly impacted coding sequence and CLIC4 is neither under strong selective 237 constraint nor known to have any link with DD Relevant clinical and annotation information for MEI and PPG de novo variants identified as part of this study. Location of the insertion event is given in hg19 240 reference coordinates (Insertion Coord.). A "True" value in the "Diagnostic" column indicates, at the time of publication, that this variant intersected a known 241 DD gene and was deemed likely to be involved in the patient's phenotype by the referring clinician. "False" does not indicate whether or not, with additional 242 future evidence, the gene may become associated with DD and the variant thus deemed diagnostically relevant. If applicable, ENSEMBL 32 gene IDs indicate 243 the gene impacted, not the gene from which the event is derived (i.e. for PPGs).
Each de novo mutation was then compared to known DD-associated genes (using 245 the Developmental Disorders Genotype-to-Phenotype database -DDG2P) to identify 246 potentially pathogenic variants (Table 2) . Of the mutations identified, four directly inserted 247 into coding exons of DD-associated genes (Fig. 3 , Table 2 ) with all four found in genes 248 statistically enriched for PTVs 12 and therefore likely to operate by a LoF mechanism. We did 249 not identify any intronic de novo mutations likely to be pathogenic ( Fig. 3a-d ; Supplemental 250 Fig. 7 ). An additional mutation inserted into the coding sequence of a strongly LoF-intolerant 251 gene, EZR (pLI = 0.99; Supplemental Fig. 7 ), but we could not directly attribute it to the 252 patient's phenotype due to lack of significant enrichment for PTVs, although there is prior 253 evidence for a role in a familial DD syndrome 33 . The four mutations in DD-associated genes 254 were reported to the referring clinician for clinical interpretation based on both initially 255 reported and updated phenotypes (Supplemental Table 3 ). Three out of four reported 256 mutations (NSD1, MEF2C, ARID2) were subsequently deemed to be likely causative of the 257 patient's phenotype ( Supplemental Table 3 ) by the referring clinician. The fourth patient, with 258 an Alu insertion in SETD5 (Fig. 3a) , has clinical features (polydactyly and truncal obesity; 259 Supplemental Table 3 ) more suggestive of a ciliopathy. As such, the identified MEI is 260 unlikely to be the sole cause for the patient's DD but may contribute to a composite 261 phenotype. 262 We also examined our dataset for inherited rare pathogenic RT variants. We 278 evaluated variants inherited from an affected parent, bi-allelic inheritance (either a 279 homozygous MEI or a heterozygous MEI paired with another variant class), and X-linked 280 variants maternally inherited by affected males. We did not identify any rare MEI variants 281 inherited from an affected parent nor any compound heterozygous individuals with a rare 282 MEI and a non-MEI PTV (e.g. SNV/InDel) impacting the same gene. We did identify a single 283 proband-specific homozygous MEI inserted into an exon of PAN2 which was unique to a 284 single family. This gene was recently identified as nominally significant (genome-wide p = 285 4.2x10 -4 ) in a study investigating the role of recessive variants in DD 13 , although more data 286 are required to be confident of its association to DD. We also identified a total of 22 (14 Alu, 287 7 L1, 1 SVA) polymorphic MEIs on the X chromosome, of which 4 (3 Alu, 1 L1) directly 288 impacted protein-coding sequence. Of these variants, none were at a low enough allele 289 frequency to be reasonably DD-associated, were located within a gene associated with DD, 290 nor fit an inheritance pattern consistent with X-linked disease. 291 292 MEI mutation rate and enrichment of deleterious RT events in DDD 293 Based on our findings, in the coding and peri-coding portion of the genome, one out 294 of every 2,434 DD cases (0.04%±0.04; 95% CI) is directly attributable to RT-derived 295 mutagenesis. To determine both if our observed number of de novo variants meets 296 expectation and if our patient cohort is enriched for causal de novo RT events, we estimated 297 the population mutation parameter, Q 34 , from the unaffected parents in the DDD study and 298 from the 1KGP 4,5 (Supplemental Table 4 ). The resulting calculation gives very similar 299 estimates of MEI mutation rate (combined across Alu, L1, SVA) of between 1.4x10 -11 (1KGP) 300 and 1. 
312
Using this genome-wide mutation rate, we estimated the number of expected 313 mutations in various genomic compartments, including within genes intolerant to PTVs and 314 within DD-associated genes ( Fig. 4; Methods) . We identified a significant enrichment of de 315 novo MEIs in dominant DD-associated genes (p = 4.82x10 -5 ), but not in the much larger set 316 of LoF intolerant genes (p = 0.05). To ensure that this finding was not due to inaccurate 317 estimation of the genome-wide mutation rate, we also assessed the probability that four out 318 of six exonic de novo MEIs would fall within exons of dominant DD-associated genes by 319 chance, based on the proportion of the exome represented by these genes (and assuming 320 known DD-associated genes have the same MEI mutation rate as other genes) and likewise 321 found a significant enrichment (p = 4.3x10 -5 ). 322 
Discussion
Here we have described the development, validation and exemplification at scale of 324 an analytical pipeline for the rapid assessment of patient genomes for RT variants. We have 325 used these approaches to present the largest study examining the coding genome for RT-326 derived variation to date (Table 1 ; Fig. 1 ). With this dataset, we first demonstrated that 327 exonic MEIs (regardless of insertion length) are under selective constraint on par with 328 protein-truncating SNVs (Fig. 2, Supplemental Fig. 5 ). We identified four likely pathogenic 329 RT mutations, two Alu and two L1 insertions (Fig. 3) , all of which arose de novo in known 330 haploinsufficient DD-associated genes ( Fig. 3a-d) , implying that dominant loss-of-function is 331 the major mode of pathogenic exonic RT variation. Finally, we estimated the genome-wide 332 MEI mutation rate and used it to determine that DDD probands are enriched for damaging 333 RT variation within exons of dominant DD-associated genes (Fig. 4a) . 334
The total number of polymorphic, exonic RT variants identified in DDD is concordant 335 with previous studies characterizing MEI variation 3,5,37 . Pathogenic MEIs make up 0.04% of 336 diagnoses in the DDD study (4/9,738 probands), a small yet individually significant collection 337 of diagnostic variants. Reassuringly, our proportion of diagnostic variants in DDD is 338 statistically identical to the 7/11,011 (0.06%) diagnostic rate for neurodevelopmental disorder 339 patients as determined by Torene et. al. 36 (Fisher's exact test p = 0.56). Unlike Torene et. 340 al. 36 , we did not identify a causative inherited MEI, although this difference is not statistically 341 significant (Fisher's exact test p = 0.51). We infer that despite making up a significant 342 proportion of reported MEI variants in the clinical literature 7 , bi-allelic or X-linked MEI events 343 are a less frequent class of pathogenic variant in developmental disorders. This is in keeping 344 with recent estimates 13 that in a largely outbred clinical population, such as in the UK, 345 recessive disorders caused by coding variants account for a much smaller fraction of 346 patients than dominant disorders. 347
Interestingly, it appears that the contribution of diagnostic RT variants may vary 4,500 neurofibromatosis type I patients (0.3% of patients). This rate is seven times higher 350 than that observed in DDD or Torene et. al. 36 and was attributed to a potential RT mutation 351 as defined by this ( Fig. 4b) and other studies 15 , previous work has identified a significant 362 signature of purifying selection against MEI events within 100bp of exons 25 -variants which 363 our study could potentially identify. As our data suggests that the majority of DD cases with 364 pathogenic coding MEIs are due to de novo insertions (Table 2; Fig. 3 ), we conjecture that 365 most additional DD-associated MEIs may be located in the introns of known DD-causing 366 genes and disrupt splicing -a known disease mechanism attributable to RT-derived 367 mutagenesis 7, 38, 40 . Simulations suggest that under a null genome-wide mutation model we 368 should expect to observe 12.5 (5.5-19.4, 95% CI) de novo intronic RT mutations in dominant 369 DD-associated genes in a population sample of 9,738 individuals. As such, a WGS study of 370 a clinical population of similar size to that analyzed here should be well powered to estimate 371 the pathogenic contribution of intronic MEIs. 372 with the source gene from which they are derived. Consequently, the WES bait capture 393 method will capture both DNA from the original "donor" gene and the new "daughter" copy. 394
This allows, compared with our approach for MEI discovery, for ascertainment of PPGs 395 genome-wide. While this approach does come with limitations, such as difficulty in 396 identifying insertion variants, we can still determine events per individual. 397
Our discovery pipeline functions in two steps: first we collect read evidence on an 398 individual level to determine which genes have been retroduplicated in that individual 399 (Supplemental Fig. 1 ). Second, we determine presence/absence of each PPG in every 400 individual in the DDD cohort based on the gene models built in the first step. In step one, we data set generation, we found that a subset of variants internal or adjacent to (±50bp) low 419 complexity repeats (defined here as a run of sequence >= 15bp composed of two or fewer 420 nucleotides) were likely false positive. As such, we added an additional filter to the final 421 MELT VCF, lc (low complexity), which removes such false positives from downstream 422 analysis. Variants that could not be genotyped in at least 25% of individuals, had £ 2 split 423 reads, had MELT ASSESS score < 3, or had any value in the VCF FILTER column other 424 than PASS or rSD were filtered. 425
To generate consequences plotted in Fig. 2a To determine if our MEI WES call set was biased compared to WGS data, we 434 performed two independent comparisons: 1.) to high coverage (>30x) WGS data generated 435 for a subset of DDD trios and 2.) to a published collection of MEIs from 1KGP phase III 5 . 436
For WGS quality-control, we used a subset of 30 DDD trios (n = 90 individuals) which 437 were previously whole genome sequenced. MEI discovery using MELT 5 on all 90 individuals 438 was performed and filtered identically to WES data. Genotypes identified in the WGS data 439 but not in WES were then separated based on coverage in the corresponding WES. 440
Genotypes in low coverage areas (<10x) were considered not possible (n.p), while variants 441
where coverage was greater than 10x are considered not detected (n.d). All remaining 442 genotypes were than compared for identity between WGS and WES results (Supplemental 443 To compare the DDD MEI call set to the 1KGP, we first filtered 1KGP calls to 445 variants with >10x coverage in 1,000 randomly sampled WES individuals (leaving 318 Alu, 446 81 L1, 26 SVA). We then randomly selected 2,453 DDD parents 1,000 times, retaining only 447 loci present in downsampled individuals 4,5 . The resulting distribution was then compared to 448 the observed number of variants in the 1KGP-masked data to generate z-scores 449 independently for all three MEI types (Supplemental Fig. 2) . 450
To compare our PPG dataset to Zhang et. al. 6 , we downloaded provided 451 supplemental tables. We then summed the total number of unique events per person and 452 Finally, all batched VCFs were passed to GenotypeGVCF to generate a final joint-called 472 VCF file. This file was then annotated used VEP v88 43 . Unaffected parents (n = 17,032 473 individuals) were then extracted from this VCF and only variants with an allele count greater 474 than 1 in these individuals were retained. 475
For initial filtering, we removed SNVs with a VQSLOD < -2.7971, depth < 10, and 476 genotype quality < 20. We next performed more extensive QC using a 'missingness' score 477 identical to the method described in Martin et. al. 13 . In short, each genotype at a given 478 variant was assessed for genotype quality (GQ), depth (DP), and a binomial test for allelic 479 depth (i.e. number of alternate versus reference supporting reads; AD). If a given genotype 480 had GQ <20, DP < 7, or AD p-value < 0.001 it was considered 'missing'. If more than 50% of 481 genotypes for a given variant were missing, the variant was subsequently filtered from final analysis. Allele frequencies were recalculated based on included individuals while 483 accounting for missing genotypes. 484 485 SNV and MEI constraint 486 As sensitivity of variant discovery can bias our results, we generated an "accessibility 487 mask" of the DDD WES data where we expect our variant ascertainment sensitivity to be 488 >95% (Supplemental Fig. 8 ) 5 . Our mask thus includes only regions of the genome that 489 contain at least 10X average coverage in a mean cohort of 1,000 randomly selected 490 individuals for a total of 74.2Mbp, or ~2.3% of the genome (Supplemental Table 4 ). Using 491 this mask, we filtered our original 1,129 variants down to 828 (660 Alu, 109 L1, 31 SVA) 492 variants in unaffected parents (n = 17,032 individuals). Parents were determined to be 493 affected either by the referring clinician or, where ambiguous, through manual curation of 494 HPO terms for a matching parent-offspring phenotype. 495
Using this mask subset of variants, we determined genomic constraint as shown in 496 Figure 2b . Allele frequency values were recalculated for all variants, and a pLI score 22 for 497 each MEI was added as described above. MEIs which did not insert into a gene or inserted 498 into a gene without a calculated pLI score 22 were excluded from subsequent analysis. We 499 then calculated proportion of singleton variants and proportion of variants in high pLI genes 500 independently for Alu and, due to low overall numbers of the other MEI subtypes, for a 501 combined set of Alu, L1, and SVA. SNVs annotated as nonsense, missense, synonymous, 502 or splice acceptor/donor (splice in Fig. 2b) as determined by VEP v88 43 were extracted from 503 the SNV VCF files described above and used to calculate singleton and pLI proportion 504 identically to MEIs. 505 506
Mobile element insertion validation by PCR 507
To validate all 9 de novo MEI variants (Table 2 ) and the homozygous insertion in 508 PAN2 we used the following PCR protocol: primers were designed using Primer3 to make products spanning the predicted insertion site (Supplemental Table 2 ). PCR was carried out 510 using Platinum™ Taq DNA Polymerase High Fidelity (Invitrogen); 20ng of genomic DNA 511 extracted from blood or saliva was amplified in the presence of 0.2 µM of each primer and 1 512 unit of Platinum™ Taq. Amplification was carried out using the following cycling conditions; 513 for Alu insertions: 2 min at 94°C, followed by 36 cycles of (30 sec at 94°C, 30 sec at 60°C 514 and 1 min at 68°C); for LINE1 insertions: 2 min at 94°C, followed by 36 cycles of (30 sec at 515 94°C, 30 sec at 60°C and 7 min at 68°C). PCR products were visualized using a 2% agarose 516 E-Gel ® (Invitrogen). 517 518 Processed pseudogene validation by PCR and capillary sequencing 519 To validate the 2 de novo PPG variants (Table 2) we used the following PCR 520 protocol: primers were designed using Primer3 to make products within the exons of each 521 gene. Forward and reverse primers were then paired between exons to amplify across the 522 excised intronic regions (Supplemental Table 2 ). PCR was carried out using either 523 Platinum™ Taq DNA Polymerase High Fidelity (Invitrogen) or Thermo-Start Taq DNA 524 Polymerase (Thermo Scientific). Platinum™ Taq assay: 20ng of genomic DNA extracted 525 from blood or saliva was amplified in the presence of 0.2 µM of each primer and 1 unit of 526 Platinum™ Taq. Amplification was carried out using the following cycling conditions; 2 min at 527 94°C, followed by 36 cycles of (30 sec at 94°C, 30 sec at 60°C and 1 min at 68°C). Thermo-528
Start Taq DNA Polymerase assay: 40 ng genomic DNA was amplified in the presence of 0.2 529 µM of each primer and 0.42 units of Thermo-Start Taq. Cycling conditions were as follows: 5 530 min at 95°C, 6 cycles of (30 sec at 95°C, 30 sec at 64°C and 1 min at 72°C), 6 cycles of (30 531 sec at 95°C, 30 sec at 62°C and 1 min at 72°C), 6 cycles of (30 sec at 95°C, 30 sec at 60°C 532 and 1 min at 72°C) followed by 36 cycles of (30 sec at 95°C, 30 sec at 58°C and 1 min at 533 72°C) with a final elongation of 10 min at 72°C. PCR products were visualized using a 2% 534 agarose E-Gel ® (Invitrogen). PCR products were sequenced using either the forward or 535 reverse primer used in the amplification protocol by Eurofins GATC Biotech GmbH.
Sequence traces were aligned using SeqMan Pro 15 (Lasergene 15) and reads were 537 aligned to the human genome (hg19) using BLAT (UCSC) 49 . 538 539 WGS of probands with de novo processed pseudogenes 540 To validate and determine the insertion site of the two identified de novo PPGs 541 (Table 2) , we performed Illumina WGS on all individuals of each trio in which the de novo 542 event was identified (n = 6 individuals). Samples were first quantified with Biotium Accuclear 543 Ultra high sensitivity dsDNA Quantitative kit using Mosquito LV liquid platform, Bravo WS 544 and BMG FLUOstar Omega plate reader and cherrypicked to 500ng / 120ul using Tecan 545 liquid handling platform. Cherrypicked plates are then sheared to 450bp using a Covaris 546 LE220 instrument and subsequently purified using SPRI Select beads on Agilent Bravo WS. 547
Library construction (ER, A-tailing and ligation) was performed using 'NEB Ultra II custom kit' 548 on an Agilent Bravo WS automation system. Samples were then tagged using NextFLEX 549 Unique Dual Indexed adapter 1-96 barcodes at the ligation stage. Libraries were then 550 quantified by qPCR using Kapa Illumina ABI Sanger custom qPCR kits using a Mosquito LV 551 liquid handling platform, Bravo WS, and Roche Lightcycler. Libraries are then pooled in 552 equimolar amounts on a Beckman BioMek NX-8 liquid handling platform and normalised to 553 2.4nM for cluster generation on a c-BOT and then sequenced on the Illumina TenX 554 sequencing platform. Following sequencing, reads were aligned with BWA mem 50 (with 555 settings -t 16 -p -Y -K 100000000) to version hg19 of the human reference genome. Reads 556 were then manually inspected using the Integrative Genomics Viewer (IGV) 51 to confirm 557 presence, de novo status, and parent of origin of each PPG. 558 559 MEI mutation rate and burden 560
To determine the mutation rate independently for each MEI type (Alu, L1, SVA), we 561 utilized data generated by both DDD and the 1KGP 5 . For DDD data we filtered sites as 562 above based on our >10X coverage accessibility mask. For the 1KGP data 5 , we created a combined mask from three different data sources: 1.) the pilot accessibility mask generated 564 by the 1KGP project phase III 52 , which removes regions of the genome inaccessible to 565 variant calling, 2.) reference ME sequences as identified by repeatmasker 53 , as MELT is 566 unable to accurately ascertain MEIs in these regions, and 3.) All sequence ±10Kbp from the 567 5' and 3' terminus of all protein-coding genes from RefSeq 54 . This mask was generated 568 separately for Alu and L1 and did not filter 1,113.0Mbp or 959.9Mbp of the genome, 569 respectively. The Alu mask was used for filtering SVA and both masks excluded both 570 allosomes. On masking the 1KGP data, we were left with a total of 10,930 autosomal MEIs 571 (8,554 Alu, 2,047 L1, 329 SVA). Following filtering of the DDD and 1KGP sets with their 572 corresponding masks, we used the Watterson estimator with an effective population size of 573 10,000 for all calculations to estimate the population mutation parameter, Q 34 , and mutation 574 rate, µ (Supplemental Table 4 ). 575
We next used or estimate of µ to determine the expected number of de novo events 576 in exons, enhancers, and introns genome-wide. Total number of genome-wide mutations to 577 simulate, 686, was determined by extrapolation of µ for 9,738 individuals. Simulated variants 578 were then annotated identically to actual variants reported in this study. Total number of 579 variants in the three categories depicted in Fig. 4 were then summed to determine the 580 Poisson l of de novo variants under neutral mutation rate and compared to number of 581 observed variants using the ppois function in R. 
